A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
From pandemics to natural disasters, clinicians share how value-based care models have enabled continuity, flexibility, and quality care when it’s needed most.
From pandemics to natural disasters, clinicians share how value-based care models have enabled continuity, flexibility, and quality care when it’s needed most.
From pandemics to natural disasters, clinicians share how value-based care models have enabled continuity, flexibility, and quality care when it’s needed most.
From pandemics to natural disasters, clinicians share how value-based care models have enabled continuity, flexibility, and quality care when it’s needed most.
Explore how value-based care providers can navigate the clinical and financial impact of emerging therapies, biosimilars, and federal drug pricing reforms.
